Anti-inflammatory agents like lactoferrin, diacerein, and resveratrol have been shown to thwart myopia progression by targeting retinal Mitogen-Activated Protein Kinase(MAPK) or Nuclear Factor kappa-B(NF-kB) signaling pathways33. The gene discussed is NFKB1; the disease is myopia.